Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

Conditions:   Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia Interventions:   Drug: Tamsulosin 0.2mg + Solifenacin 5mg;   Drug: Tamsulosin 0.2mg + Placebo(Solifenacin) Sponsor:   Jeil Pharmaceutical Co., Ltd. Recruiting - verified November 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials